Literature DB >> 16538425

High prolactin levels as a worsening factor for migraine.

C Cavestro1, A Rosatello, M P Marino, G Micca, G Asteggiano.   

Abstract

Many factors should be considered when an episodic migraine worsens and becomes chronic. Prolactin (PRL) was linked to the origin of pain in patients with microprolactinomas who developed different types of headaches. Our team carried out studies on 27 patients with a background of episodic headaches that became chronic. The patients were evaluated by means of a general examination, a neurological examination and a hormonal profile. Of the 27 patients, 7 of them had an increased level of prolactinaemia. All the patients were women, ranging from 17 to 57 years of age. Four of them had a pure form of migraine without aura, whereas 3 patients had both migraines without aura and tension-type headaches. They suffered from headache for a period ranging from 3 to 32 years and their headache became chronic 4-12 months prior to the visit. Their headache did not change in type, but only in severity and frequency. Two patients had no symptoms referable to high PRL levels; 4 patients had irregular menses or amenorrhoea. One of these patients also suffered galactorrhoea and two of these patients had a microprolactinoma at MRI; one patient was using estroprogestinic drugs, so her menstrual alteration could not be considered. The patients were followed-up for a period of 6-16 months. Six patients responded favourably after being treated with cabergoline, although some had already tried other drugs, which, however, had no effect on their headache. One patient improved after ceasing to take estroprogestinic, in spite of increased levels of PRL. Therefore, on this basis, PRL levels should always be considered when headache worsens. It is an adjunctive worsening factor, which can be easily eliminated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16538425      PMCID: PMC3451702          DOI: 10.1007/s10194-006-0272-8

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  13 in total

Review 1.  Prolactin receptor in regulation of neuronal excitability and channels.

Authors:  Mayur J Patil; Michael A Henry; Armen N Akopian
Journal:  Channels (Austin)       Date:  2014       Impact factor: 2.581

2.  Identification of a novel ANKK1 and other dopaminergic (DRD2 and DBH) gene variants in migraine susceptibility.

Authors:  Jayashri Ghosh; Sunil Pradhan; Balraj Mittal
Journal:  Neuromolecular Med       Date:  2012-08-09       Impact factor: 3.843

Review 3.  How to investigate and treat: headache and hyperprolactinemia.

Authors:  Gennaro Bussone; Susanna Usai; Franca Moschiano
Journal:  Curr Pain Headache Rep       Date:  2012-08

4.  Prolactin signaling modulates stress-induced behavioral responses in a preclinical mouse model of migraine.

Authors:  Bianca N Mason; Rohini Kallianpur; Theodore J Price; Armen N Akopian; Gregory O Dussor
Journal:  Headache       Date:  2021-12-29       Impact factor: 5.887

5.  [Migraine recurrence due to intracranial metastasis of a thyroid carcinoma].

Authors:  C J Schankin; J Wagner; M Elstner; V M Reinisch; A Straube
Journal:  Nervenarzt       Date:  2008-04       Impact factor: 1.214

6.  Neuroendocrine Mechanisms Governing Sex Differences in Hyperalgesic Priming Involve Prolactin Receptor Sensory Neuron Signaling.

Authors:  Candler Paige; Priscilla A Barba-Escobedo; Jennifer Mecklenburg; Mayur Patil; Vincent Goffin; David R Grattan; Gregory Dussor; Armen N Akopian; Theodore J Price
Journal:  J Neurosci       Date:  2020-08-12       Impact factor: 6.167

7.  Relationship between high prolactin levels and migraine attacks in patients with microprolactinoma.

Authors:  D Bosco; A Belfiore; A Fava; M De Rose; M Plastino; C Ceccotti; P Mungari; R Iannacchero; A Lavano
Journal:  J Headache Pain       Date:  2008-02-07       Impact factor: 7.277

8.  The prolactin receptor long isoform regulates nociceptor sensitization and opioid-induced hyperalgesia selectively in females.

Authors:  Yanxia Chen; Aubin Moutal; Edita Navratilova; Caroline Kopruszinski; Xu Yue; Megumi Ikegami; Michele Chow; Iori Kanazawa; Shreya Sai Bellampalli; Jennifer Xie; Amol Patwardhan; Kenner Rice; Howard Fields; Armen Akopian; Volker Neugebauer; David Dodick; Rajesh Khanna; Frank Porreca
Journal:  Sci Transl Med       Date:  2020-02-05       Impact factor: 17.956

9.  PREDICT: a method for inferring novel drug indications with application to personalized medicine.

Authors:  Assaf Gottlieb; Gideon Y Stein; Eytan Ruppin; Roded Sharan
Journal:  Mol Syst Biol       Date:  2011-06-07       Impact factor: 11.429

Review 10.  Sensory Neurons, Neuroimmunity, and Pain Modulation by Sex Hormones.

Authors:  Melissa E Lenert; Amanda Avona; Katherine M Garner; Luz R Barron; Michael D Burton
Journal:  Endocrinology       Date:  2021-08-01       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.